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To the Editor:  47 
The novel coronavirus disease (COVID-19), an infection due to the severe acute respiratory syndrome 48 
coronavirus 2 (SARS-CoV-2) that may cause interstitial pneumonia and respiratory failure, has 49 
currently taken on pandemic proportions.
1
 COVID-19 outbreak has emerged in Wuhan (China) and 50 
has rapidly spread to Europe, particularly to Italy
2
, where, as of to date (April 1, 2020), 80572 people 51 
have tested positive.
3
 52 
Two recent publications have brought attention to COVID-19-associated cutaneous manifestations.
4,5
 53 
Joob et al. reported on a dengue-like petechial rash in a COVID-19 patient from Thailand.
4
 Recalcati 54 
described 18 out of 88 COVID-19 patients hospitalized in the Lecco Hospital (Lombardy region, Italy) 55 
who developed erythematous rash (n=14), widespread urticaria (n=3) or varicella-like vesicles (n=1).
5
  56 
During the Italian outbreak, we have observed a varicella-like papulovesicular exanthem as a rare but 57 
specific COVID-19-associated skin manifestation. Eight Italian Dermatology Units collected clinical 58 
data of patients with COVID-19 (microbiologically proven by nasopharyngeal swab) and no history of 59 
new medications in the previous 15 days who developed varicella-like lesions. 60 
Demographic and clinical features of the 22 patients are summarized in Table 1.  61 
Male patients were 72.7% (n=16/22) and the median age was 60 years. Most patients (n=17/22; 62 
77.3%) came from Lombardy, currently the worst-hit region in Italy, while the remaining patients 63 
came from Piedmont (n=1), Emilia-Romagna (n=1), Toscana (n=1), Lazio (n=1), and Campania (n=1). 64 
Median latency time from systemic symptoms to exanthem was three days (range from -2 to 12 65 
days). Median duration of skin manifestations was eight days (range= 4 – 15 days). Lesions were 66 
scattered in most cases (n=16; 72.7%), while they were diffuse in six (27.3%) cases. Predominance of 67 
vesicles was observed in 12 (54.5%) patients. No variations in the papulovesicular presentation were 68 
observed in our case series.  Trunk was constantly involved, in some cases in association with limbs 69 
(n=4; 18.2%). (Fig. 1a-d) No facial or mucosal involvements were scored. Itching, which was generally 70 
mild, was reported in nine (40.9%) patients. In all the patients who underwent skin biopsy (n=7), 71 
histology was consistent with viral infection. (Fig. 1e-f) 72 
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Most common systemic symptoms were fever (n=21/22; 95.5%), followed by cough (n=16; 72.7%), 73 
headache (n=11; 50%), weakness (n=11; 50%), coryza (n=10; 45.5%), dyspnea (n=9; 40.9%), hyposmia 74 
(n=4; 18.2%), hypogeusia (n=4; 18.2%), pharyngodynia (n=1; 4.5%), diarrhea (n=1; 4.5%), myalgia 75 
(n=1; 4.5%). Death occurred in three (13.6%) patients.  76 
Ours is the first series on this varicella-like exanthem as a specific COVID-19-associated cutaneous 77 
picture, unlike the non-specific cutaneous manifestations such as erythematous rash or urticaria 78 
reported by Recalcati.
5
 Its typical features are constant trunk involvement, usually scattered 79 
distribution and mild/absent pruritus, the latter being in line with most viral exanthems but unlike 80 
true varicella. Lesions generally appear 3 days after systemic symptoms and disappear upon 8 days, 81 
without leaving scarring.  A limitation of our study was missing histology in some cases. Moreover, 82 
demonstration of SARS-CoV-2 presence by Polymerase Chain Reaction in lesional skin was not 83 
possible due to specific primer unavailability. If further studies validate our findings, this early skin 84 
manifestation will represent a useful clue to suspect COVID-19 in asymptomatic/paucisymptomatic 85 
patients.  86 
87 
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LEGENDS AND FIGURES 109 
TABLE 1. Demographic and clinical data of patients with varicella-like exanthem associated with COVID-19  110 
Id  Sex Age Hometo
wn  
Date of 
symptoms’ 
onset  
Date of 
nasopharyngeal 
swab 
positivization 
Skin lesions  Skin 
symptoms 
Latency 
time 
(days) 
Duration 
(days) Localization 
Systemic 
symptoms 
Nasopharyngeal 
swab 
negativization 
Course 
1 M 75 Rome February 19, 2020 March 4, 2020 
Diffuse papulovesicular 
lesions (predominance 
of papules) 
No itching  12 5 Trunk 
Fever, asthenia, 
hypogeusia, 
hyposmia 
Yes Resolution 
2 M 57 Milan February 20, 2020 
February 22, 
2020 
Diffuse papulovesicular 
lesions (predominance 
of vesicles) 
Mild itching  5 4 Trunk 
Fever, cough, 
coryza, 
headache, 
hyposmia, 
hypogeusia, 
weakness 
Yes Resolution  
3 M 59 Milan February 28, 2020 March 2, 2020 
Scattered 
papulovesicular lesions 
(predominance of 
papules) 
Mild itching 7 15 Trunk  
Fever, cough, 
pharyngodynia, 
headache, 
weakness 
Yes Resolution 
4 F 56 Brescia February 28, 2020 March 2, 2020 
Scattered 
papulovesicular lesions 
(predominance of 
vesicles) 
Pain 3 15 Trunk 
Fever, cough, 
coryza, 
headache, 
weakness 
Yes Resolution 
5 M 28 Bologna March 1, 2020 March 10, 2020 
Diffuse papulovesicular 
lesions started 
(predominance of 
papules) 
Itching 4 7 Trunk Fever, cough Yes Resolution 
6 M 45 Biella March 1, 2020 March 6, 2020 
Scattered 
papulovesicular lesions 
(predominance of 
papules) 
No itching  6 10 Trunk  Fever, diarrhea, 
nausea 
Yes Resolution  
7 M 72 Brescia March 1, 2020 March 14, 2020 
Scattered 
papulovesicular lesions 
(predominance of 
vesicles) 
No itching  Unknown  NA Trunk, limbs 
Fever, cough, 
coryza, 
headache, 
dyspnea 
No Active disease 
8 M 83 Cremona March 2, 2020 March 10, 2020 
Scattered 
papulovesicular lesions 
(predominance of 
vesicles)  
No itching 2 5 Trunk  Fever, dyspnea No Active disease* 
9 M 61 Milan March 2, 2020 March 5, 2020 
Diffuse papulovesicular 
lesions (predominance 
of vesicles) 
Mild itching 2  4 Trunk 
Fever, cough, 
dyspnea, coryza, 
headache, 
weakness 
// Death 
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10 M 29 Brescia March 3, 2020 March 10, 2020 
Scattered 
papulovesicular lesions 
(predominance of 
vesicles) 
Mild itching  1 12 Trunk  Fever, cough, 
weakness Yes Resolution  
11 M 65 Brescia March 3, 2020 March 16, 2020 
Scattered   
papulovesicular lesions 
(predominance of 
papules) 
Burning 2 13 Trunk  
Fever, cough, 
dyspnea, coryza, 
headache, 
weakness 
No Active disease 
12 M 44 Brescia March 8, 2020 March 16, 2020 
Scattered 
papulovesicular lesions 
(predominance of 
vesicles)  
Burning, 
itching 3 8 Trunk  
Fever, cough, 
coryza, 
headache, 
weakness 
No Resolution 
13 M 75 Cremona March 8, 2020 March 16, 2020 
Scattered vesicular 
lesions (predominance 
of vesicles)  
No itching  0 8 Trunk, limbs Fever, dyspnea // Death  
14 F 51 Brescia March 8, 2020 March 17, 2020 
Scattered 
papulovesicular lesions  
(predominance of 
vesicles) 
Pain 4 8 Trunk  
Fever, cough, 
dyspnea, coryza, 
headache, 
weakness 
No Active disease 
15 F 62 Brescia March 9, 2020 March 18, 2020 
Scattered 
papulovesicular lesions 
(predominance of 
papules) 
Burning 2 11 Trunk  
Fever, cough, 
coryza, 
headache, 
weakness 
No Improvement 
16 M 25 Siena March 10, 2020 March 17, 2020 
Diffuse papulovesicular 
lesions (predominance 
of vesicles) 
Itching 5 6 Trunk, limbs Cough, hyposmia, hypogeusia No Resolution 
17 F 90 Cremona March 12, 2020 March 20, 2020 
Scattered 
papulovesicular lesions 
(predominance of 
vesicles)  
No itching 1 6 Trunk 
Fever, cough, 
dyspnea, coryza, 
headache, 
weakness 
No Active disease 
18 F 69 Brescia March 12, 2020 March 20, 2020 
Scattered 
papulovesicular lesions 
(predominance of 
papules) 
No itching  Unknown  NA Trunk  
Fever, cough, 
dyspnea, coryza, 
hyposmia, 
hypogeusia, 
headache, 
weakness 
No Active disease 
19 M 65 Naples March 13, 2020 March 20, 2020 
Diffuse papulovesicular 
lesions (predominance 
of papules) 
Mild Itching -2 9 Trunk Fever, cough No  Improvement  
20 M 80 Brescia March 14, 2020 March 22, 2020 
Scattered 
papulovesicular lesions 
(predominance of 
vesicles)  
No itching  Unknown NA Trunk, limbs  Fever, dyspnea // Death 
21 M 43 Milan March 15, 2020 March 23, 2020 
Scattered 
papulovesicular  
lesions (predominance 
of vesicles) 
Mild itching  0 11 Trunk  Fever, myalgia No Active disease 
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22 F 8 Milan March 15, 2020 March 24, 2020 
Scattered 
papulovesicular lesions 
(predominance of 
papules) 
No itching 3 7 Trunk Fever, cough No Resolution 
*, patient with acute respiratory distress symptoms (ARDS) in intensive care unit 111 
NA, not available 112 
 113 
FIGURE 1. A, B, C, D. Papulovesicular exanthem on the trunk in four patients with COVID-19. In three patients (A, B and C), predominance of papules is seen. 114 
In another patient (D) mainly presenting with vesicles, exanthem resolution with crusts is evident; E, Basket-wave hyperkeratosis, slightly atrophic 115 
epidermis, vacuolar degeneration of the basal layer with multinucleate, hyperchromatic keratinocytes and dyskeratotic cells. Note the absence of 116 
inflammatory infiltrate. Hematoxylin and eosin stain original magnification: x4; F, Close-up with atrophic epidermis, vacuolar alteration with disorganized 117 
keratinocytes lacking orderly maturation, enlarged and multinucleate keratinocytes with dyskeratotic (apoptotic) cells. Hematoxylin and eosin stain, original 118 
magnification: x20 119 
 120 

